Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Sacituzumab tirumotecan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
TNBC - Triple-Negative Breast Cancer
1 trial -
Self-hypnotic Relaxation
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Breast Cancer
1 trial -
TAX625
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Breast Cancer
1 trial -
TNG348
Tango Therapeutics
Breast Cancer
1 trial -
TQB3616 capsules
Chia Tai Tianqing Pharmaceutical Group Co.,
HR-positive, HER2-negative Advanced Breast Cancer
1 trial -
TRC105
United Therapeutics Europe Ltd
Metastatic Breast Cancer
1 trial -
Tak-228 & Tak-117
Takeda
Triple Negative Breast Cancer
1 trial -
Talazoparib Tosylate
BioMarin Pharmaceutical Australia Pty Ltd
Advanced Breast Cancer
1 trial -
Taxotere
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Tegafur Gimeracil Oteracil Potassium Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Temsirolimus
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
Toripalimab
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Toripalimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Triple-Negative Breast Cancer (TNBC)
1 trial -
Trastuzumab
KAZIA THERAPEUTICS LTD
Breast Cancer
1 trial -
Tumor infiltrating lymphocytes (TIL) LN-145
Iovance Biotherapeutics B.V.
Metastatic Triple Negative Breast Cancer
1 trial -
Utidelone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Vitamin D
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
ZW25 (Zanidatamab)
Jazz Pharmaceuticals Ireland Limited
HER2+/HR+ Breast Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
HER2-positive Breast Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Breast Cancer
1 trial -
Zn-Telomir
Telomir Pharmaceuticals
Triple-Negative Breast Cancer (TNBC)
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Breast Cancer
1 trial -
chidamide，fulvestrant
The First People's Hospital of Lianyungang
Hormone Receptor-positive Advanced Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.